REQUEST A DEMO
Total
USD $0.00
Search more companies

Universal Chemsol Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Universal Chemsol Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Universal Chemsol Private Limited is an enterprise in India, with the main office in South Delhi. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. Universal Chemsol Private Limited was incorporated on December 20, 2011. The latest financial highlights indicate a net sales revenue drop of 17.37% in 2025. During that time, Universal Chemsol Private Limited’s total assets decreased by 4.59%. Universal Chemsol Private Limited’s net profit margin increased by 0.3% in 2025.

Legal Address
Flat No 05, First Floor Building No 59, Gautam Nagar
South Delhi; Delhi; Postal Code: 110049

Contact Details: Purchase the Universal Chemsol Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Universal Chemsol Private Limited report to view the information.
Financial Auditors:
Purchase the Universal Chemsol Private Limited report to view the information.
Incorporation Date:
December 20, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Universal Chemsol Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.37%
Total Operating Revenue
-16.66%
Operating Profit
84.24%
EBITDA
31.34%
Net Profit/Loss for the Period
83.1%
Total Assets
-4.59%
Total Equity
5.72%
Operating Profit Margin
0.83%
Net Profit Margin
0.3%
Return on Equity (ROE)
2.29%
Debt / Equity
33%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?